Biotechnology & Health Care

When people are asked what they think of when they hear the word biotechnology, they respond with phrases like "biomedical research," "breakthrough medicines," "cures" and "hope for the future." Health care is, after all, the number one market for biotechnology.

A majority of BIO members are engaged in biomedical research, and to date such companies have brought 254 new medicines to market. In 2005 alone, the FDA approved 39 new biotech products and indications

BIO and its members seek to develop and bring these products to patients in a way that is expeditious, maximizes patient access and encourages continued innovation. Those goals sound simple, but achieving them requires a complex, delicately balanced legal and regulatory environment at every level - state, national and international. BIO is the leading industry voice at all those levels.